Hallmarks of Aging Library
Every article, presentation, spotlight, and news item we've tagged to Hallmarks of Aging.
Showing 49–72 of 401
A Review of How the Heart Ages
The heart undergoes progressive cellular dysfunction with age, driven by mitochondrial impairment, cellular senescence, and fibrosis, with heart failure prevalence increasing from 1% in those under 55 to over 10% in those over 70. Understanding these mechanisms is essential for developing targeted interventions against age-related cardiac disease.
SIRT1 Downregulation by Advanced Glycation End Products Activates RANKL‐Dependent Osteoclast Signaling and Drives Chondrocyte Senescence During Osteoarthritis Development
Advanced glycation end products suppress SIRT1 expression in osteoclasts, triggering RANKL-dependent bone resorption and accelerated chondrocyte senescence—a mechanism that directly couples metabolic stress to cartilage degradation in osteoarthritis. This pathway represents a biochemical link between systemic glucose metabolism and joint degeneration, suggesting that metabolic control earlier in life may alter osteoarthritis trajectory.
Global rallies call for aging to be treated
Coordinated global demonstrations are pressuring governments to fund geroscience research and establish regulatory pathways that recognize aging as a treatable medical condition. The rallies highlight a critical gap between accelerating scientific advances in longevity research and stalled policy frameworks that remain anchored to disease-specific treatment models.
Cellular Desynchronization Drives Ovarian Aging
Reproductive decline with age stems from progressive loss of spatiotemporal coordination across ovarian cell populations, not from individual cell senescence. This finding reframes aging in reproductive tissue as a systems-level coordination problem, with implications for understanding how tissue-wide synchronization deteriorates across other organ systems during aging.
Neuron-specific mitophagy decline reveals aging's uneven cognitive impact
Selective removal of damaged mitochondria varies by neuron type in aging brains, with certain cells losing mitophagy capacity earlier than others. This cell-specific decline in mitochondrial quality control directly impacts neural energy metabolism and may explain differential cognitive aging patterns across brain regions.
The MICOS Complex Regulates Mitochondrial Structure and Oxidative Stress During Age‐Dependent Structural Deficits in the Kidney
The MICOS complex, a structural regulator of mitochondrial cristae, deteriorates with age in kidney tissue, leading to fragmented mitochondria, elevated oxidative stress, and impaired energy metabolism. This structural collapse represents a discrete mechanism linking cellular aging to the progressive loss of kidney function observed in older adults.
Sex differences in aging demand mechanistic study, not statistical adjustment
Women outlive men globally yet experience higher rates of disability and age-related disease in those extra years—a disparity rooted in biological sex differences, reproductive aging trajectories, and menopause's systemic effects. GeroSCORE, a new $7.5 million NIH-funded center at USC, is designed to move beyond documenting these differences toward identifying the mechanistic underpinnings that could reveal intervention points applicable across populations.
Senescent Cell Pathways: Primary vs Secondary Origins
Research distinguishes primary senescent cells (induced by direct damage like radiation) from secondary senescent cells (induced by signals from neighboring senescent cells). This heterogeneity in senescent cell populations has direct implications for understanding aging progression and designing interventions targeting cellular senescence.
Aging Liver CD44 Suppresses Immune T Cells
Hepatocytes in aging livers upregulate CD44, triggering IL6/STAT3 signaling that impairs T cell function in surrounding tissue. This mechanism reveals how aging in one organ system compromises immune competence at the cellular level, with implications for infection resistance and tumor surveillance in older adults.
Senescent Cell Distribution Across Tissues Enables Targeted Aging Intervention
Senescent cells accumulate across tissues with age and vary significantly by organ type and species, revealing tissue-specific patterns of cellular aging. This spatiotemporal map establishes a foundation for understanding which senescent populations drive age-related decline and represent therapeutic targets for longevity interventions.
Microglial Metabolism Drives Cognitive Aging
Microglia—the brain's immune cells—undergo metabolic shifts with age that correlate with chronic inflammation and increased risk of neurodegenerative disease. These metabolic changes are reversible targets for intervention, offering a mechanistic pathway to slow cognitive decline and protect against Alzheimer's and Parkinson's disease.
Forever Young explores the longevity revolution
A new documentary translates geroscience research into accessible language for public audiences, emphasizing that lifestyle and environmental factors—not genetic destiny—are the primary drivers of aging outcomes. This shift from genetic determinism to behavioral agency represents a critical moment in moving longevity science from laboratory to practical application.
Senescence at the crossroads of postpartum remodeling and tumorigenesis
Cellular senescence plays a dual role in postpartum mammary gland remodeling—supporting normal tissue reorganization while simultaneously creating conditions that enhance tumor progression when oncogenic events coincide with gland involution. This mechanism reveals how a normally protective cellular state becomes pathogenic under specific developmental and genetic circumstances.
Neuronal Protein Disposal Failure Drives Alzheimer's Tau Pathology
A neuron-specific protein disposal mechanism called the membranal proteasome has been identified as a key player in tau aggregation and Alzheimer's pathology. This finding reframes neurodegeneration not as a mutation problem but as a failure in cellular quality control, with direct implications for how protein misfolding accumulates in the aging brain.
Inferring Gene Regulatory Network Architecture Underlying Complex Traits: An Integrative Analysis of Mutant Lifespan and Gene Expression Profiles Identifies Master Regulators and Key Functional Modules for Yeast Aging
Researchers identified a hierarchical gene regulatory network controlling yeast lifespan, where peripheral genes act through master regulators that converge on functional modules governing stress response, autophagy, and proteostasis. This architecture provides a framework for dissecting genetic complexity in aging and maps directly to mechanisms that influence human longevity pathways.
Cellular and spatial remodeling of aging breast tissue revealed
Imaging mass cytometry analysis of breast tissue from 527 women reveals that aging is accompanied by decreased cellular density and proliferation, concurrent with increased proportions of inflammatory immune cells. These findings establish a cellular and spatial signature of breast aging that reflects broader patterns of tissue remodeling seen across the body.
Senescence Trajectories Shift Strategy Windows
Cellular senescence markers and inflammatory pathways show distinct trajectories across age cohorts, with implications for identifying intervention windows in age-related disease progression. Understanding how these signals diverge allows for more precise targeting of longevity strategies before irreversible decline.
HSC Bias, Not Aging, Drives Thymic T Cell Decline
Age-related decline in T cell output from the thymus results primarily from a shift in bone marrow HSCs toward myeloid bias rather than from intrinsic aging of individual stem cells. Single-cell clonal analysis in artificial thymic organoids shows T cell differentiation capacity remains intact in aged HSPCs, pointing to compositional rather than functional cellular deterioration.
p21 + TREM2 + senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease
Senescent macrophages expressing p21 and TREM2 accumulate with age and drive chronic inflammation and metabolic dysfunction in the liver. This identification of a specific senescent immune cell phenotype directly connects cellular aging to systemic metabolic decline and suggests a mechanistic target for interventions addressing age-related disease.
Reduction of glycation stress as a geroscience intervention: protocol for a pilot RCT in postmenopausal women
A pilot randomized controlled trial investigates whether reducing glycation stress—the accumulation of sugar-derived damage to proteins—can slow aging markers in postmenopausal women. Glycation is a hallmark of aging that accelerates decline across multiple physiological systems, making this intervention relevant to the practical toolkit of longevity medicine.
Gut Senescence Drives Age-Related Immune Dysfunction
Spatial proteomics mapping of aged mouse gut tissue reveals localized accumulation of senescent immune cells near the epithelial barrier, metabolic reprogramming through mTOR upregulation, and compartment-specific immune exhaustion in lymphoid regions. These interconnected molecular alterations indicate progressive dysregulation of intestinal immune homeostasis, with direct implications for age-related loss of mucosal barrier resilience.
Peroxisomal Function Controls Metabolic Flexibility in Aging
Peroxisomal decline during aging impairs the mobilization of stored lipids, leading to metabolic rigidity and secondary mitochondrial dysfunction. Restoring peroxisomal function restores metabolic flexibility and resilience, positioning peroxisomal health as a causal driver of age-related metabolic decline rather than a consequence.
Dynamin‐Related Protein 1‐Dependent Disruption of Mitochondrial Homeostasis Drives Blue Light‐Induced Epithelial‐Mesenchymal Transition in Retinal Aging
Blue light exposure triggers excessive mitochondrial fragmentation in retinal cells through a specific protein (Drp1), driving cellular changes associated with age-related macular degeneration. Blocking this fragmentation restores mitochondrial function and reverses the pathological transformation in both cell cultures and animal models.
The ‘rising tide’ of mitochondrial therapies in longevity
Mitochondrial dysfunction is increasingly recognized as a central mechanism underlying age-related disease, not merely a feature of rare genetic conditions. The FDA approval of elamipretide (Forzinity) for Barth syndrome represents the first regulatory validation of mitochondria-targeted therapeutics, positioning this class of drugs as potential interventions for common age-related conditions including neurodegeneration and cardiac disease.